Xinhua News Agency, Geneva, November 26 (Reporter Liu Qu) The latest data released by the World Health Organization on the 26th showed that the cumulative number of confirmed cases of new crown worldwide exceeded 60 million, reaching 6,074,174.

  Data show that as of 18:38 on the 26th Central European Time (1:38 on the 27th, Beijing time), the number of confirmed cases worldwide increased by 577,198 compared with the previous day, reaching 6,074,174; the number of deaths increased by 11,263, reaching 1,416,292.

  The cumulative number of confirmed cases in the United States, India, and Brazil ranks among the top three in the world.

The United States has a total of 12,441,925 confirmed cases and a total of 257,825 deaths; India has a total of 9,266,705 confirmed cases and a total of 135,223 deaths; Brazil has a total of 6,118,708 confirmed cases and a total of 170,115 deaths.

  Countries with more cumulative confirmed cases include Russia, France, Spain, Britain, Italy, Argentina, Colombia, Mexico, Germany, etc.

  The number of new confirmed cases of new crown every day in the world has repeatedly hit new highs since October.

On November 9th, there were more than 50 million confirmed cases worldwide, and it took 17 days to go from 50 million to 60 million.

  The WHO previously expressed “very concerned” about the recent surge in cases in some countries in the Americas and Europe.

WHO Director-General Tedros Adhanom Ghebreyesus warned on the 16th that countries that allow the virus to spread uncontrollably are "it is tantamount to playing with fire", which will cause more unnecessary death and suffering.

  Tan Desai said on the 23rd that recent progress has been made in clinical trials of a number of new crown candidate vaccines worldwide. The combination of vaccines and other public health measures that have been tested and proven to be effective is used to end the epidemic. "Now there is real hope." .

  As of November 12, countries have reported to the WHO more than 200 new coronavirus vaccine candidates, 48 ​​of which are in clinical trials.

A number of candidate vaccines have achieved encouraging initial test results.